Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil Versus Propofol With Target Controlled Infusion Effect Site for the Sedation of Patients During Gastrointestinal Endoscopic Procedures: Randomized Controlled Trial

NCT01746641 is registered in ClinicalTrials.gov with Fundación Universitaria de Ciencias de la Salud as lead sponsor.

NCT NCT01746641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil Versus Propofol With Target Controlled Infusion Effect Site for the Sedation of Patients During Gastrointestinal Endoscopic Procedures: Randomized Controlled Trial
Lead sponsor
Fundación Universitaria de Ciencias de la Salud
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2010
Completion date
June 30, 2010
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain